Drug trial aims to speed recovery from dangerous brain bleeds
NCT ID NCT06504576
Summary
This study is testing if a drug called cilostazol can help the body clear a blood clot faster after a type of stroke called an intracerebral hemorrhage (brain bleed). Researchers will enroll 100 patients and give half of them cilostazol for two weeks along with standard care, while the other half receives standard care only. The main goal is to see if the drug safely reduces the size of the brain bleed and improves patients' recovery over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICH - INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, Not Required For This Country, 100225, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.